Patents by Inventor Arthur Driscoll

Arthur Driscoll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GELMA POLYMER COMPOSITIONS AND USES THEREOF
    Publication number: 20240374792
    Abstract: The present disclosure describes improved polymer compositions, such as GelMA polymer compositions. In certain embodiments, the improved polymer compositions can be used as a soft-tissue adhesive for use in sealing, repairing and/or treating injuries, defects, or diseases in the soft tissue of a subject. In certain embodiments, the improved polymer compositions are hydrogels which can comprise gelatin methacryloyl (i.e., GelMA) or polymerically crosslinked derivatives thereof.
    Type: Application
    Filed: September 15, 2022
    Publication date: November 14, 2024
    Inventors: Max COTLER, Noel VERA-GONZALEZ, Arthur DRISCOLL, Eric HUANG
  • OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS
    Publication number: 20240285518
    Abstract: Provided herein are sustained-release biodegradable ocular hydrogel implants which are useful in the treatment of certain ocular conditions.
    Type: Application
    Filed: February 21, 2024
    Publication date: August 29, 2024
    Inventors: Peter Jarrett, Rami El-Hayek, Timothy S. Jarrett, Zachary Lattrell, Arthur Driscoll, Charles D. Blizzard
  • HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE
    Publication number: 20240165018
    Abstract: Provided herein are sustained release biodegradable ocular hydrogel implants which are useful for lowering ocular pressure and for treating related conditions.
    Type: Application
    Filed: October 27, 2023
    Publication date: May 23, 2024
    Inventors: Michael Goldstein, Arthur Driscoll, Charles D. Blizzard, Ankita Desai
  • OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
    Publication number: 20230390189
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: October 26, 2021
    Publication date: December 7, 2023
    Inventors: Charles D. BLIZZARD, Arthur DRISCOLL, Rami EL-HAYEK, Michael GOLDSTEIN, Joseph IACONA, Peter JARRETT, Timothy S. JARRETT, Erica KAHN, Zachary LATTRELL
  • COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
    Publication number: 20230285281
    Abstract: The present invention relates to the treatment of ocular diseases in a human subject. In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.
    Type: Application
    Filed: December 14, 2022
    Publication date: September 14, 2023
    Inventors: Charles D. Blizzard, Ankita Desai, Arthur Driscoll, Michael Goldstein
  • OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
    Publication number: 20230285282
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 14, 2023
    Publication date: September 14, 2023
    Inventors: Charles D. BLIZZARD, Arthur DRISCOLL, Rami EL-HAYEK, Michael GOLDSTEIN, Joseph IACONA, Peter JARRETT, Timothy S. JARRETT, Erica KAHN, Zachary LATTRELL
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20230118774
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: November 21, 2022
    Publication date: April 20, 2023
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles
    Patent number: 11622935
    Abstract: The present invention relates to the treatment of ocular diseases in a human subject In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: April 11, 2023
    Assignee: OCULAR THERAPEUTIX, INC.
    Inventors: Charles D. Blizzard, Ankita Desai, Arthur Driscoll, Michael Goldstein
  • OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS
    Publication number: 20230040637
    Abstract: Provided herein are sustained-release biodegradable ocular hydrogel implants which are useful in the treatment of certain ocular conditions.
    Type: Application
    Filed: August 3, 2022
    Publication date: February 9, 2023
    Inventors: Peter Jarrett, Rami El-Hayek, Timothy S. Jarrett, Zachary Lattrell, Arthur Driscoll, Charles D. Blizzard
  • Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor
    Patent number: 11534396
    Abstract: This invention relates to methods of treatment with a sustained release biodegradable ocular implant containing a tyrosine inhibitor dispersed in a hydrogel.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: December 27, 2022
    Assignee: Ocular Therapeutix, Inc.
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • INTRACAMERAL DRUG DELIVERY DEPOTS
    Publication number: 20220401356
    Abstract: Methods of treating an eye for an ocular condition such as placing a composite depot comprising a xerogel with embedded degradable particles into an anterior chamber of an eye to deliver a therapeutic agent. The xerogel is a hydrogel after exposure to intraocular fluid and is degradable. The degradable particles comprise the therapeutic agent and hydrolytically degrade in the anterior chamber to provide a controlled release of the therapeutic agent into the eye. Materials and processes for making depots are provided as well as alternative methods of their use.
    Type: Application
    Filed: August 18, 2022
    Publication date: December 22, 2022
    Inventors: Amarpreet S. Sawhney, Arthur Driscoll, Charles D. Blizzard, Ankita D. Desai, Peter Jarrett
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20220347094
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: May 13, 2022
    Publication date: November 3, 2022
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Ocular implant containing a tyrosine kinase inhibitor
    Patent number: 11439592
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: September 13, 2022
    Assignee: Ocular Therapeutix, Inc.
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
    Publication number: 20220218643
    Abstract: The present invention relates to the treatment of ocular diseases in a human subject In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.
    Type: Application
    Filed: February 16, 2022
    Publication date: July 14, 2022
    Inventors: Charles D. Blizzard, Ankita Desai, Arthur Driscoll, Michael Goldstein
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20220079876
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 24, 2021
    Publication date: March 17, 2022
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20210308043
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 24, 2021
    Publication date: October 7, 2021
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Compositions and Methods for Treating Ocular Diseases
    Publication number: 20210251893
    Abstract: The present invention relates to the treatment of ocular diseases in a human subject. In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 19, 2021
    Inventors: Charles D. Blizzard, Ankita Desai, Arthur Driscoll, Michael Goldstein
  • COATED IMPLANTS
    Publication number: 20210077299
    Abstract: A prosthesis comprising a water-dissolvable coating. A prosthesis for a lacrimal canaliculus comprising a swellable punctal plug with a proximal end and a distal end, with the plug comprising a water-dissolvable biocompatible coating on the distal and/or the proximal end. Materials and methods for making and using the same. A prosthesis for placement in or across natural or prosthetic lumens, ostia, ducts, sinus, or sphincters, the prosthesis comprising a coating. The prosthesis can further provide a depot for sustained drug delivery to tissue.
    Type: Application
    Filed: March 3, 2020
    Publication date: March 18, 2021
    Inventors: Peter Jarrett, Amarpreet S. Sawhney, Michael J. McGrath, Arthur Driscoll, Ankita D. Desai, Michael Bassett
  • HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE
    Publication number: 20200337990
    Abstract: Provided herein are sustained release biodegradable ocular hydrogel implants which are useful for lowering ocular pressure and for treating related conditions.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 29, 2020
    Inventors: Michael Goldstein, Arthur Driscoll, Charles D. Blizzard, Ankita Desai
  • OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS
    Publication number: 20200337989
    Abstract: Provided herein are sustained-release biodegradable ocular hydrogel implants which are useful in the treatment of certain ocular conditions.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 29, 2020
    Inventors: Peter Jarrett, Rami El-Hayek, Timothy S. Jarrett, Zachary Lattrell, Arthur Driscoll, Charles D. Blizzard